JP2002526499A5 - - Google Patents

Download PDF

Info

Publication number
JP2002526499A5
JP2002526499A5 JP2000574109A JP2000574109A JP2002526499A5 JP 2002526499 A5 JP2002526499 A5 JP 2002526499A5 JP 2000574109 A JP2000574109 A JP 2000574109A JP 2000574109 A JP2000574109 A JP 2000574109A JP 2002526499 A5 JP2002526499 A5 JP 2002526499A5
Authority
JP
Japan
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2000574109A
Other languages
Japanese (ja)
Other versions
JP2002526499A (ja
JP4145492B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP1999/006899 external-priority patent/WO2000017200A1/en
Publication of JP2002526499A publication Critical patent/JP2002526499A/ja
Publication of JP2002526499A5 publication Critical patent/JP2002526499A5/ja
Application granted granted Critical
Publication of JP4145492B2 publication Critical patent/JP4145492B2/ja
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

JP2000574109A 1998-09-23 1999-09-17 テトラヒドロピリドエーテル Expired - Lifetime JP4145492B2 (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
EP19843504.5 1998-09-23
DE19843504 1998-09-23
EP98117988 1998-09-23
EP98117988.0 1998-09-23
PCT/EP1999/006899 WO2000017200A1 (en) 1998-09-23 1999-09-17 Tetrahydropyridoethers

Publications (3)

Publication Number Publication Date
JP2002526499A JP2002526499A (ja) 2002-08-20
JP2002526499A5 true JP2002526499A5 (cg-RX-API-DMAC10.html) 2005-11-17
JP4145492B2 JP4145492B2 (ja) 2008-09-03

Family

ID=26049024

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2000574109A Expired - Lifetime JP4145492B2 (ja) 1998-09-23 1999-09-17 テトラヒドロピリドエーテル

Country Status (31)

Country Link
US (4) US6436953B1 (cg-RX-API-DMAC10.html)
EP (1) EP1115725B1 (cg-RX-API-DMAC10.html)
JP (1) JP4145492B2 (cg-RX-API-DMAC10.html)
KR (1) KR100668400B1 (cg-RX-API-DMAC10.html)
CN (2) CN1155598C (cg-RX-API-DMAC10.html)
AT (1) ATE231862T1 (cg-RX-API-DMAC10.html)
AU (1) AU763463B2 (cg-RX-API-DMAC10.html)
BG (1) BG65195B1 (cg-RX-API-DMAC10.html)
BR (1) BR9914044A (cg-RX-API-DMAC10.html)
CA (1) CA2344251A1 (cg-RX-API-DMAC10.html)
CZ (1) CZ292335B6 (cg-RX-API-DMAC10.html)
DE (1) DE69905178T2 (cg-RX-API-DMAC10.html)
DK (1) DK1115725T3 (cg-RX-API-DMAC10.html)
EA (1) EA005377B1 (cg-RX-API-DMAC10.html)
EE (1) EE04677B1 (cg-RX-API-DMAC10.html)
ES (1) ES2191464T3 (cg-RX-API-DMAC10.html)
GE (1) GEP20032926B (cg-RX-API-DMAC10.html)
HK (1) HK1038360B (cg-RX-API-DMAC10.html)
HR (1) HRP20010224A2 (cg-RX-API-DMAC10.html)
HU (1) HUP0102990A3 (cg-RX-API-DMAC10.html)
ID (1) ID28896A (cg-RX-API-DMAC10.html)
IL (2) IL142063A0 (cg-RX-API-DMAC10.html)
NO (1) NO317304B1 (cg-RX-API-DMAC10.html)
NZ (1) NZ510610A (cg-RX-API-DMAC10.html)
PL (1) PL193616B1 (cg-RX-API-DMAC10.html)
PT (1) PT1115725E (cg-RX-API-DMAC10.html)
RS (1) RS50145B (cg-RX-API-DMAC10.html)
SI (1) SI1115725T1 (cg-RX-API-DMAC10.html)
SK (1) SK285165B6 (cg-RX-API-DMAC10.html)
TR (1) TR200100805T2 (cg-RX-API-DMAC10.html)
WO (1) WO2000017200A1 (cg-RX-API-DMAC10.html)

Families Citing this family (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EA005377B1 (ru) 1998-09-23 2005-02-24 Алтана Фарма Аг ТЕТРАГИДРОИМИДАЗО [1,2-h][1,7] НАФТИРИДИНОВЫЕ СОЕДИНЕНИЯ
ES2199810T3 (es) * 1999-04-17 2004-03-01 Altana Pharma Ag Haloalcoxi-imidazonaftiridinas.
CA2721484A1 (en) * 1999-05-12 2000-11-12 President And Fellows Of Harvard College Dopamine transporter imaging agents
MXPA02009551A (es) * 2000-03-29 2004-05-14 Altana Pharma Ag Profarmacos de derivados de imidazopiridina.
IL151198A0 (en) * 2000-03-29 2003-04-10 Altana Pharma Ag Tricyclic imidazopyridine derivatives and pharmaceutical compositions containing the same
JP2004512338A (ja) * 2000-10-25 2004-04-22 アルタナ ファルマ アクチエンゲゼルシャフト 胃液分泌抑制剤としてのポリ置換イミダゾピリジン
UA80393C2 (uk) 2000-12-07 2007-09-25 Алтана Фарма Аг Фармацевтична композиція, яка містить інгібітор фде 4, диспергований в матриці
US20040082605A1 (en) * 2001-03-08 2004-04-29 Arne Eek Use
US6927292B2 (en) 2001-08-02 2005-08-09 Altana Pharma Ag Tricyclic epoxides
EP1417208A1 (en) * 2001-08-03 2004-05-12 ALTANA Pharma AG Amino-substituted imidazopyridines for the treatment of gastrointestinal diseases
NZ531433A (en) * 2001-08-03 2005-09-30 Altana Pharma Ag Alkyl-substituted imidazopyridines for the treatment of gastrointestinal disorders
HRP20040834A2 (en) 2002-02-15 2005-06-30 Altana Pharma Ag Tricyclic n-acyl compounds
MY140561A (en) 2002-02-20 2009-12-31 Nycomed Gmbh Dosage form containing pde 4 inhibitor as active ingredient
MXPA04011018A (es) * 2002-05-07 2005-01-25 Altana Pharma Ag Nueva combinacion de inhibidores reversibles de la bomba de protones y productos terapueticos para tratar trastornos de las vias respiratorias.
NZ540504A (en) 2002-11-19 2007-12-21 Altana Pharma Ag 8-Substituted imidazopyridines for the treatment of gastrointestinal disorders
US7879833B2 (en) 2002-12-12 2011-02-01 Nycomed Gmbh Combination medicament
BR0316752A (pt) * 2002-12-20 2005-10-25 Altana Pharma Ag Silil éteres
PL377581A1 (pl) * 2003-02-17 2006-02-06 Altana Pharma Ag Połączenia zawierające imidazopirydyny oraz ich zastosowanie do leczenia chorób zapalnych przewodu pokarmowego
DK1606261T3 (da) 2003-03-10 2010-01-18 Nycomed Gmbh Hidtil ukendt fremgangsmåde til fremstilling af roflumilast
TW200503783A (en) * 2003-04-11 2005-02-01 Altana Pharma Ag Oral pharmaceutical preparation for proton pump antagonists
SA04250092B1 (ar) * 2003-05-14 2008-05-04 التانا فاروا ايه جي مركب وسيط جديد لتحضير مركبات إيميدازوبيريدين imidazopyridines فعالة علاجياً
RS20050868A (sr) * 2003-05-27 2007-08-03 Altana Pharma Ag., Farmaceutske kombinacije inhibotora protonske pumpe i jedinjenje koje modifikuje gastrointestinalni motilitet
BRPI0414046A (pt) * 2003-08-29 2006-10-24 Dynogen Pharmaceuticals Inc método de tratamento de um distúrbio de motilidade gastrintestinal, de tratamento de "gerd", de "gerd" noturno, composição farmacêutica, kit que compreende um composto e método para aumentar a motilidade esofágica em um paciente
WO2005025578A1 (en) 2003-09-16 2005-03-24 Altana Pharma Ag Use of ciclesonide for the treatment of respiratory diseases
US20080280944A1 (en) * 2003-11-03 2008-11-13 Paula Fernstrom Imidazo[1,2-A]Pyridine Derivatives For The Treatment Of Silent Gastro-Esophageal Reflux
EP1697358A1 (en) 2003-12-19 2006-09-06 Altana Pharma AG Intermediates for the preparation of tricyclic dihydropyrano -imidazo -pyridines derivatives
AR047605A1 (es) * 2004-02-17 2006-01-25 Altana Pharma Ag Imidazopiridinas triciclicas e intermediarios en la sintesis de las mismas,sus procesos de preparacion,composiciones farmaceuticas que los contienen y usos.
PL1784404T3 (pl) 2004-09-03 2012-04-30 Yuhan Corp Pochodne pirolo[2,3-c]pirydyny i sposoby ich wytwarzania
MX2007002214A (es) 2004-09-03 2007-05-07 Yuhan Corp Derivados de pirrolo[3,2-c]piridina y procesos para su preparacion.
BRPI0514695A (pt) 2004-09-03 2008-06-17 Yuhan Corp derivados de pirrol[3, 2-b]piridina e processos para a preparação destes
EP2258350B1 (en) * 2005-03-16 2014-12-24 Takeda GmbH Taste masked dosage form containing roflumilast
EP2080513A1 (en) 2008-01-16 2009-07-22 Schraermeyer, Ulrich, Prof. Dr. rer. nat Tetrahydropyridoethers for treatment of AMD
JP5802898B2 (ja) * 2009-07-09 2015-11-04 ラクオリア創薬株式会社 消化管運動異常が関与する疾患を治療するためのアシッドポンプ拮抗剤
WO2012027240A1 (en) * 2010-08-23 2012-03-01 Schering Corporation Fused tricyclic inhibitors of mammalian target of rapamycin
CN104428292B (zh) * 2012-06-15 2017-02-08 生物药品解决方案有限公司 氨基磺酸苯基烷基酯化合物及包含所述化合物的肌肉松弛组合物
WO2015052256A1 (en) 2013-10-08 2015-04-16 Katairo Gmbh Tetrahydropyridoethers for the treatment of stargardt's disease

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4468400A (en) * 1982-12-20 1984-08-28 Schering Corporation Antiulcer tricyclic imidazo [1,2-a]pyridines
CA1327796C (en) * 1987-07-16 1994-03-15 Jorg Senn-Bilfinger Diazoles
SE9401197D0 (sv) * 1994-04-11 1994-04-11 Astra Ab Active compounds
JPH10505332A (ja) * 1994-07-28 1998-05-26 ビイク グルデン ロンベルク ヒェーミッシェ ファブリーク ゲゼルシャフト ミット ベシュレンクテル ハフツング アシルイミダゾピリジン
CA2284747A1 (en) * 1997-03-24 1998-10-01 Byk Gulden Lomberg Chemische Fabrik Gmbh Tetrahydropyrido compounds
HUP0001555A3 (en) * 1997-10-30 2001-01-29 Altana Pharma Ag Tetrahydro-imidazo-naphthyridine derivatives, pharmaceutical compositions thereof and process for their preparation
EA005377B1 (ru) 1998-09-23 2005-02-24 Алтана Фарма Аг ТЕТРАГИДРОИМИДАЗО [1,2-h][1,7] НАФТИРИДИНОВЫЕ СОЕДИНЕНИЯ

Similar Documents

Publication Publication Date Title
BE2018C020I2 (cg-RX-API-DMAC10.html)
BE2015C057I2 (cg-RX-API-DMAC10.html)
BE2016C007I2 (cg-RX-API-DMAC10.html)
BE2015C018I2 (cg-RX-API-DMAC10.html)
BE2014C017I2 (cg-RX-API-DMAC10.html)
JP2002525694A5 (cg-RX-API-DMAC10.html)
BE1025464I2 (cg-RX-API-DMAC10.html)
BE2008C046I2 (cg-RX-API-DMAC10.html)
BE2010C011I2 (cg-RX-API-DMAC10.html)
BRPI0017527B8 (cg-RX-API-DMAC10.html)
JP2002500922A5 (cg-RX-API-DMAC10.html)
JP2002518111A5 (cg-RX-API-DMAC10.html)
BE2008C047I2 (cg-RX-API-DMAC10.html)
BE2011C004I2 (cg-RX-API-DMAC10.html)
BRPI0001672A2 (cg-RX-API-DMAC10.html)
JP2002507572A5 (cg-RX-API-DMAC10.html)
BRPI0001542A2 (cg-RX-API-DMAC10.html)
BRPI0012675B8 (cg-RX-API-DMAC10.html)
BRPI0017522A2 (cg-RX-API-DMAC10.html)
BRPI9917761A2 (cg-RX-API-DMAC10.html)
BRMU7902607U2 (cg-RX-API-DMAC10.html)
BRPI0303609A (cg-RX-API-DMAC10.html)
IN191700B (cg-RX-API-DMAC10.html)
AU2000262176A8 (cg-RX-API-DMAC10.html)
CN3098146S (cg-RX-API-DMAC10.html)